A real-world pharmacovigilance analysis of ALK inhibitor-associated pleural and pericardial effusion using the FDA Adverse Events Reporting System (FAERS) database from 2013 to 2024

Open Access

Peer-reviewed

Research Article

Reader Comments (0)

Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Pleurae
Is the Subject Area "Pleurae" applicable to this article?

Thanks for your feedback.
Drug safety
Is the Subject Area "Drug safety" applicable to this article?

Thanks for your feedback.
Pleural effusion
Is the Subject Area "Pleural effusion" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Oncology
Is the Subject Area "Oncology" applicable to this article?

Thanks for your feedback.